Unknown

Dataset Information

0

PYK-1105: Preclinical Evaluation of a Novel Biodegradable Vitreous Substitute for Retinal Tamponade.


ABSTRACT:

Purpose

Current retinal tamponade strategies are limited by anatomic considerations (retinal break location), durability (short-term vs need for removal), and patient adherence (positioning, travel/altitude restrictions). Here we describe the preclinical safety and toxicology of a novel biodegradable hydrogel tamponade agent (PYK-1105) with the potential to improve both patient experience and outcomes after retina surgery.

Methods

We studied in vitro performance to assess hydrogel gelation time, modulus, viscosity, degradation time, refractive index, and transmittance. In addition to studying in vitro and in vivo (mice and rabbits) biocompatibility, testing was performed to assess cytotoxicity, intraocular irritation, acute systemic toxicity, genotoxicity, and pyrogenicity. Furthermore, clinical safety was assessed using in vivo (rabbits and minipigs) response to vitrectomy with PYK-1105 insertion with the following measures: clinical examination, multimodal imaging, full-field electroretinography, and histopathology.

Results

PYK-1105 met the predefined performance testing criteria for optimal tamponade and demonstrated excellent biocompatibility. Animal studies showed the PYK-1105 formulation to be well tolerated and nontoxic in mice, rabbits, and pigs.

Conclusions

PYK-1105 holds promise as a new biodegradable tamponade agent that has the potential to improve both the patient experience and outcomes after retina surgery. Human pilot studies are warranted to further assess for safety and efficacy.

SUBMITTER: Stryjewski TP 

PROVIDER: S-EPMC9976048 | biostudies-literature | 2021 Jan-Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

PYK-1105: Preclinical Evaluation of a Novel Biodegradable Vitreous Substitute for Retinal Tamponade.

Stryjewski Tomasz P TP   Stefater James A JA   Roth Larry L   Li Jun J   Awh Carl C CC   Moshfeghi Darius M DM   Kim Leo A LA   Eliott Dean D  

Journal of vitreoretinal diseases 20200901 1


<h4>Purpose</h4>Current retinal tamponade strategies are limited by anatomic considerations (retinal break location), durability (short-term vs need for removal), and patient adherence (positioning, travel/altitude restrictions). Here we describe the preclinical safety and toxicology of a novel biodegradable hydrogel tamponade agent (PYK-1105) with the potential to improve both patient experience and outcomes after retina surgery.<h4>Methods</h4>We studied in vitro performance to assess hydrogel  ...[more]

Similar Datasets

| S-EPMC3653144 | biostudies-other
| S-EPMC9750099 | biostudies-literature
| S-EPMC4053724 | biostudies-literature
| S-EPMC7960944 | biostudies-literature
| S-EPMC7143394 | biostudies-literature
| S-EPMC9754973 | biostudies-literature
| S-EPMC11384602 | biostudies-literature
| S-EPMC5939173 | biostudies-literature
| S-EPMC7363691 | biostudies-literature
| S-EPMC9834476 | biostudies-literature